Sun Pharma Advanced Research Company Ltd (SPARC)


📊 End of Day Bhavcopy

Date: 2025-09-09

Price: 141.90
% Change: 0.72% (Prev Close: 140.88)

Volume: 1,52,188
% Change: -50.21% (Prev Volume: 3,05,679)

Delivery: 65,856
Delivery % : 43.27
% Change: -62.57% (Prev Delivery: 1,75,943)

Turnover: 215 Lacs
% Change: -50.76% (Prev Turnover: 437)

💹 EOD Valuation

P/E Ratio: 0.00
P/B Ratio: 0.00
Market Cap: 4605 Rs. Cr.



Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: SPARC
Market Cap: 4546 Rs. Cr.
Face Value: 1.00 Rs.

52 Week High: 241.00
52 Week Low: 109.20

All-Time High: 593.96 Rs.
All-Time Low: 35.18 Rs.


Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
0.75% | -11.31% | 7.48% | -34.97% | -13.63%


👥 Shareholding Pattern

Promoter Holding

Promoter Holding: 65.67%

Change (3Y | 1Y): -3.42% | 0.00%

Pledged %: 0.00%

FII Holding

FII Holding: 1.47%

Change (3Y | 1Y): -0.93% | 0.02%

DII Holding

DII Holding: 0.97%

Change (3Y | 1Y): 0.21% | -0.16%

Public Holding: 31.88%


🏦 Financial Strength

Debt to Equity: 0.45
Debt: 265.40 Rs. Cr.

Book Value: -6.80 Rs.
Current Ratio: 0.07
Interest Coverage: -19.62
Free Cash Flow: -372.16 Rs. Cr.


📈 Growth & Sales

Sales Growth: -5.57%

Sales Growth Qtr (YOY | QoQ):
-42.65% | -64.55%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
-1.35% | -19.44% | -5.57%


💰 Profit & Earnings

Profit Growth %

Profit Growth: 22.89%

Profit Growth Qtr (YOY | QoQ):
46.27% | 14.68%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
-1.73% | -30.04% | 22.89%


EPS Rs.

EPS (TTM): -9.26 Rs.

EPS Qtr (Last Year | Latest):
-2.98 Rs. | -1.60 Rs.

EPS Annual (Last Annual | Annual March):
-11.96 Rs. | -10.64 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
2.39% | -15.13%


Net Profit Rs. Cr.

Net Profit (TTM): -300.41 Rs. Cr.

Net Profit (Annual - March): -345.22 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
-96.84| -60.98 | -52.03


EBITDA Rs. Cr.

EBITDA (Quarter): -43.31 Rs. Cr.
EBITDA (Previous Yr Ql): -93.56 Rs. Cr.

EBITDA (Annual - March): -325.51 Rs. Cr.
EBITDA (Previous Annual): -374.90 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
-1.27% | -37.99%


📊 Profitability Ratios

Operating Margin (OPM)

OPM (TTM): -440.37%

OPM Qtr (Previous | Current):
-198.31% | -542.84%

OPM Annual (5 Yrs | Last Yr | March):
-163.17% | -534.47% | -456.00%


Return on Equity %

ROE: 0.00%

ROE (5 Yrs | 3 Yrs | Last Yr):
0.00% | 0.00% | -121.92%


Return on Capital Employed %

ROCE: -297.83%

ROCE (5 Yrs | 3 Yrs | Last Yr):
-186.86% | -158.06% | -109.10%


Return on Assets %

ROA (TTM): -84.66%

ROA (5 Yrs | 3 Yrs | Last Yr):
-65.16% | -61.26% | -59.05%



PEG Ratio: 0.00
Dividend Yield: 0.00%

PE 3 Yrs: 0.00
PE 5 Yrs: 0.00

Dividend Yield: 0.00%


👥 Company

Sun Pharma Advanced Research Company Ltd

SPARC

Promoter Holding: %